Department of Cardiology, Medical University of Lublin, Lublin, Poland.
2nd Department of Cardiology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia in Katowice, Katowice, Poland.
Sci Rep. 2022 Jun 10;12(1):9601. doi: 10.1038/s41598-022-13769-y.
Adults with cardiac implantable electronic devices (CIEDs) implanted at an early age constitute a specific group of patients undergoing transvenous lead extraction (TLE). The aim of this study is to assess safety and effectiveness of TLE in young adults. A comparative analysis of two groups of patients undergoing transvenous lead extraction was performed: 126 adults who were 19-29 years old at their first CIED implantation (early adulthood) and 2659 adults who were > 40 years of age at first CIED implantation and < 80 years of age at the time of TLE (middle-age/older adulthood). CIED-dependent risk factors were more common in young adults, especially longer implant duration (169.7 vs. 94.0 months). Moreover younger age of patients at first implantation, regardless of the dwell lead time, is a factor contributing to the greater development of connective tissue proliferation on the leads (OR 2.587; p < 0.001) and adhesions of the leads with the heart structures (OR 3.322; p < 0.001), which translates into worse TLE results in this group of patients. The complexity of procedures and major complications were more common in younger group (7.1 vs. 2.0%; p < 0.001), including hemopericardium (4.8 vs 1.3; p = 0.006) and TLE-induced tricuspid valve damage (3.2 vs.0.3%; p < 0.001). Among middle-aged/older adults, there were 7 periprocedural deaths: 6 related to the TLE procedure and one associated with indications for lead removal. No fatal complications of TLE were reported in young adults despite the above-mentioned differences (periprocedural mortality rate was comparable in study groups 0.3% vs 0.0%; p = 0.739). Predictors of TLE-associated major complications and procedure complexity were more likely in young adults compared with patients aged > 40 to < 80 years. In younger aged patients prolonged extraction duration and higher procedure complexity were combined with a greater need for second line tools. Both major and minor complications were more frequent in young adults, with hemopericardium and tricuspid valve damage being predominant.
在早年植入心脏植入式电子设备 (CIED) 的成年患者构成了进行经静脉导线拔除术 (TLE) 的特定患者群体。本研究旨在评估年轻成年人 TLE 的安全性和有效性。对两组接受经静脉导线拔除术的患者进行了比较分析:126 名患者在首次植入 CIED 时年龄为 19-29 岁(青年期),2659 名患者首次植入 CIED 时年龄大于 40 岁且小于 80 岁(中年/老年期)。在年轻患者中,CIED 依赖风险因素更为常见,尤其是植入时间更长(169.7 与 94.0 个月)。此外,无论留置导线时间如何,患者的初次植入年龄较小,都是导致导线上结缔组织增生和导线与心脏结构粘连更为严重的因素(OR 2.587;p<0.001),这导致该组患者的 TLE 结果更差。年轻组的手术复杂性和主要并发症更为常见(7.1%与 2.0%;p<0.001),包括血心包(4.8%与 1.3%;p=0.006)和 TLE 引起的三尖瓣损伤(3.2%与 0.3%;p<0.001)。在中年/老年组中,有 7 例围手术期死亡:6 例与 TLE 手术相关,1 例与导线拔除指征相关。尽管存在上述差异,年轻患者并未报告 TLE 的任何致命并发症(研究组围手术期死亡率为 0.3%与 0.0%;p=0.739)。与年龄大于 40 岁至小于 80 岁的患者相比,年轻患者更有可能发生与 TLE 相关的主要并发症和手术复杂性的预测因素。在年轻患者中,延长拔除时间和增加手术复杂性与更需要二线工具相结合。年轻患者的主要和次要并发症更为常见,以血心包和三尖瓣损伤为主。